Field Force Sizing And Territory Design

The following discussion illustrates a project that is well suited to the capabilities of an independent consultant in the Umbrex Biotechnology Practice. This is an illustrative example. Umbrex consultants adapt their methodology, timeline, and deliverables to the specific needs of each client.

1) Client Situation

The client operated within the therapeutics-focused biotech ecosystem and required support with Field Force Sizing And Territory Design in the context of Biotechnology. Teams across Emerging Therapeutic Biotech (Preclinical), Clinical-Stage Biotech (Phase I–III), Commercial Biotech (Post-Approval), Platform Biotech (Therapeutic Discovery), and Biotech Investors & Incubators asked for a rigorous, analytics-driven approach to determine the optimal field force size, design equitable territories, and build CRM call plans and routing that maximized healthcare professional (HCP) coverage and productivity for specialty therapeutics. The diagnostic surfaced the following pain points and gaps:

• Fragmented targeting and potential models. HCP targeting relied on legacy deciles or static volume tiers rather than dynamic potential (eligible patient counts, diagnostic intensity, access frictions, and adoption propensity). Account-level (IDN/health system) influence was under-modeled, leading to misallocated calls.
• Uneven coverage and workload imbalance. Territories varied widely in HCP counts, travel time, and reachable call volume. High-value clusters were underserved; some reps exceeded realistic call capacities while others underutilized time, degrading coverage and call quality.
• CRM call plans not aligned to brand strategy. Frequency goals (CFT%—call-frequency target attainment) lacked linkage to expected lift; plan adherence was inconsistent; rep-triggered non-personal promotion (NPP) and peer-to-peer follow-up were not orchestrated with field cycles.
• Poor integration with access realities. Call plans did not reflect payer policy intensity (step edits/PA), HUB performance, or site-of-care economics. Reps spent time where access friction limited conversion, while access-enabled targets received insufficient attention.
• Travel and routing inefficiencies. Territories were laid out by sales history rather than drive-time clusters. Route plans did not minimize windshield time; weekly routing lacked geospatial optimization and calendar discipline, reducing calls-per-day.
• Limited account-based posture. Key accounts (IDNs, health systems, group practices) lacked coordinated coverage across roles (sales, field reimbursement, medical), causing duplicative touchpoints or gaps in decision-maker engagement.
• Inadequate span of control and coaching leverage. District design did not reflect travel burdens and rep density; managers struggled to coach consistently across dispersed territories; new-hire onboarding timelines were not built into coverage models.
• Data and tooling gaps. CRM (e.g., Veeva) fields were incomplete; HCP master and affiliation data (NPI-to-facility mapping, prescriber-to-system linkages) were outdated; third-party data (claims/diagnostics) were underutilized; KPI dashboards lacked lineage and consistency across brands.
• Compliance and access restrictions. Clinics with access limitations were over-assigned; sample accountability and signatory rules were not consistently encoded in call plan logic; virtual/digital alternatives were not integrated for no-see or restricted accounts.
• Unclear ROI narrative. Leadership lacked a defensible bridge from headcount and territory choices to NBRx, TRx, and share lift, complicating budget approvals and investor communications.

Indicative KPIs reflected underperformance: CFT% below threshold on high-potential HCPs, reach <80% in priority segments, calls-per-day below 7–8 in urban territories and 5–6 in rural, call plan adherence <70%, CLM sequence completion and dwell time low, share-of-voice below target in key accounts, NBRx lift inconsistent with targeting expectations, and high variance in travel time across territories. Managers reported limited time for coaching, and reps cited route inefficiencies and misaligned goals.

2) Project Objective

The primary objective focused on optimizing field force size, territory design, CRM call plans, and routing—grounded in potential modeling, geospatial analytics, and access-aware prioritization—to increase HCP reach, CFT%, and productivity, thereby improving NBRx/TRx and share growth while maintaining compliance and coordination with medical and market access teams.

Secondary objectives included:

• Building an evidence-based HCP/account potential model (eligible patient flow, diagnostic/testing intensity, adoption propensity, access frictions) to inform targeting tiers and call frequency.
• Right-sizing the field force with a capacity model (calls-per-day, travel time, visit duration mix, virtual touchpoints) and span-of-control design for districts/regions.
• Designing balanced territories using geospatial clustering (drive-time) and affiliation overlays (IDN/system influence) to equalize workload and opportunity.
• Developing CRM call plans and cadence rules that maximize CFT% on priority segments and integrate rep-triggered NPP and peer-to-peer follow-ups.
• Implementing routing optimization and weekly planning (sequence and time windows) to reduce windshield time and increase effective calls per day.
• Institutionalizing account-based coverage (IDN playbooks) that coordinate sales, field reimbursement, and medical engagement within compliance boundaries.
• Standing up dashboards and governance to monitor coverage, CFT%, adherence, call quality (CLM metrics), access signals, and NBRx/TRx, with clear escalation thresholds.
• Embedding a continuous improvement and refresh cadence for potential models, territories, and call plans as access, competition, and evidence evolve.

3) Methodology and Approach

Workstream 1: Targeting, Potential Modeling, and Segmentation

We quantified HCP and account opportunity using integrated datasets and adoption analytics.

• Data assembly: combined HCP master (NPI, specialty), affiliations (IDN/system, group practice), de-identified claims (diagnosis/procedure proxies for eligible patients), testing/diagnostics volume, historical NBRx/TRx (where available), and access signals (PA/step edits by plan, HUB BV/PA approval rates).
• Potential model: estimated eligible patient flow by HCP using epidemiology × diagnostic intensity × access adjusters; layered adoption propensity (historical trialing, peer influence, academic/community, recency/frequency, digital engagement).
• Segmentation: created tiers (A/B/C) and micro-segments (e.g., evidence-driven early adopters vs. cost-sensitive protocol followers) with target call frequency bands and content needs; identified “network magnets” (KOLs, system protocol influencers).
• Validation: stress-tested model against field insights and brand performance; refined with manager and MSL input to ensure clinical plausibility and local knowledge.

Workstream 2: Field Force Sizing and Capacity Modeling

We sized the team to deliver required coverage and frequency within realistic capacity constraints.

• Capacity model: calculated calls-per-day by territory archetype (urban, suburban, rural), in-office vs. virtual mix, average visit duration, and travel time distributions; projected CFT% under different headcount scenarios.
• Scenario design: compared headcount options (baseline, lean, growth), considering onboarding ramp, vacancy buffers, manager span of control, and co-promotion or contract sales options.
• Optimization: selected the minimal headcount achieving target reach/CFT% in high-priority tiers with a safety margin for access variability and seasonal effects.

Workstream 3: Territory Design and Alignment

We created balanced, travel-efficient territories using geospatial and affiliation-aware methods.

• Geospatial clustering: grouped HCPs with K-means and hierarchical clustering over drive-time matrices (not straight-line distance), respecting natural travel corridors.
• Affiliation overlays: ensured IDN/system clusters and referral patterns were unified within territories where strategically appropriate; anticipated cross-functional account plans.
• Workload balancing: equalized territories on a composite index (target calls × average travel time × access friction), not just HCP counts; enforced guardrails (max/min territory size, call volume variance, travel time caps).
• Sales management design: built districts/regions with coherent travel patterns, manageable spans (6–10 reps per district), and coaching capacity; defined realignment triggers (new data, access changes, competitor moves).

Workstream 4: Call Plan Design, Cadence, and Integration With Omnichannel

We engineered call plans that translate strategy to field execution and integrate with digital/peer tactics.

• Call frequency bands: assigned call frequency by segment to achieve target CFT% and expected lift; included cadence rules (e.g., front-loading in post-launch months, maintenance cycles later).
• Omnichannel coordination: set triggers for rep-triggered emails, portal content, and peer-to-peer invites following CLM completion; codified suppression windows after high-quality visits to prevent fatigue.
• Compliance hooks: encoded access restrictions, sample rules, and signatory needs; flagged modules requiring specific disclosures or alternative virtual visits.
• Dynamic refresh: aligned monthly/quarterly refresh cadence to incorporate new access signals, HUB performance, and plan policy changes.

Workstream 5: Routing Optimization and Weekly Planning

We reduced windshield time and raised calls-per-day through route design and time-windowing.

• Routing engine: applied traveling-salesperson and vehicle-routing heuristics with time windows to sequence visits; respected office hours, rep availability, and distance thresholds.
• Weekly plans: produced “smart weeks” per rep with optimized daily clusters, anchor appointments, and contingency options for cancellations.
• Operating norms: instituted planning discipline (e.g., lock routes Friday for the following week), buffer for weather/traffic, and real-time adjustments using CRM mobile tools.

Workstream 6: Account-Based Coverage (IDN/Health Systems)

We aligned field roles around key accounts to influence protocols and pathway decisions.

• Account maps: identified decision-makers (P&T, service line heads), champions, and barriers; defined joint goals with field reimbursement and medical (within promotional boundaries).
• Coverage plans: sequenced engagement across roles; set meeting objectives and SLAs for sharing insights; used account-level KPIs (protocol inclusion, diagnostic flow increases).
• Governance: established account review cadence to prevent overlap and ensure coherent value delivery.

Workstream 7: Dashboards, KPIs, and Governance

We built measurement and governance to sustain performance and compliance.

• Dashboard suite: reach, CFT%, call plan adherence, calls-per-day, travel time per call, CLM completion/dwell, rep-triggered email usage, peer-to-peer attendance, NBRx/TRx by segment/territory; account KPIs (protocol adoption, formulary wins).
• Lineage and refresh: KPI dictionary with data sources (CRM, claims/diagnostics, HUB), transformations, and refresh cadence; compliance review of content variants and targeting rules.
• Governance cadence: monthly field ops reviews with managers, quarterly territory refreshes, and biannual sizing checks; escalation thresholds for under-coverage or travel inefficiency.

Workstream 8: Change Management, Training, and Field Enablement

We enabled adoption through practical tools and coaching support.

• Training: routing tools, CRM call plan navigation, IDN account planning, CLM best practices; manager coaching guides and ride-along checklists.
• Playbooks: territory transition guides, objection handling for access-restricted offices, virtual call workflows; FAQs for new alignment.
• Incentives: aligned incentive compensation to CFT% on priority segments, call quality (CLM metrics), and account outcomes, not just volume.

Workstream 9: Compliance, Privacy, and Risk Controls

We ensured compliance and privacy were embedded in design and execution.

• Data governance: role-based access in CRM; de-identified patient-level analytics; adherence to CCPA/GDPR equivalents where applicable; SOPs for data retention.
• Promotional boundaries: clear separation of roles from medical; sample accountability; approved content use; documentation for audits.
• Monitoring: alerts for over-calling restricted sites, sample anomalies, and off-label risks; corrective action workflows.

4) Data Request

We requested detailed datasets to execute field force sizing, territory design, and call plan optimization. Typical horizons were 18–36 months; monthly or weekly granularity where available.

• HCP and account data:
  • HCP master: NPI, specialty, addresses, affiliation (IDN/system, group practice), target status; access restrictions; sample eligibility/signatory rules.
  • Account hierarchy: health system/IDN rosters, P&T committees, service lines, site-of-care footprint (clinic/hospital/ASC).
• Demand and potential signals:
  • De-identified claims (diagnosis/procedure codes, treatment history), diagnostic/testing volumes, hub metrics (BV/PA approval rates/time), historic NBRx/TRx (if applicable), peer-to-peer and CLM engagement.
• Access context:
  • Payer policy by geo/plan (PA, step edits, tiering), formulary status, specialty pharmacy/SP/SD distribution footprint.
• Field activity and CRM:
  • Veeva (or equivalent) call history, call duration, CLM completion/dwell, approved email sends, call plan adherence, rep-triggered NPP usage; manager ride-along notes if available.
• Geospatial and travel:
  • Rep home bases, office hours, drive-time matrices or road network data, weather/seasonality considerations.
• Org and performance:
  • Headcount, manager spans, vacancy history, onboarding times; incentive compensation metrics; territory boundaries; prior realignments and impacts.
• Systems and governance:
  • KPI dictionary, dashboard definitions, data lineage; SOPs for targeting, sampling, content use; compliance alerts history.

Common data pitfalls included outdated HCP affiliations, missing access restriction flags, inconsistent addresses (resulting in poor geocoding), incomplete CLM metadata, under-reported hub metrics, and absent payer policy overlays. We instituted data cleansing, master data stewardship (HCP/account), and validation routines prior to modeling.

5) Questions for Client

• What are the primary goals of the field redesign (e.g., maximize CFT% on Tier A, lift reach, reduce travel time, accelerate account protocol adoption)?
• Which HCP segments and accounts are strategic in the next 6–12 months, and what frequency/cadence do they require?
• What constraints must we honor (access limitations, sample signatory rules, co-promotion carve-outs, union rules, IDN contracting)?
• How should we balance in-person vs. virtual calls; what content or service elements differentiate high-quality visits?
• What call-per-day expectations are realistic by archetype (urban/suburban/rural), and what travel time thresholds are acceptable?
• Which metrics will govern success (CFT%, reach, adherence, call quality/CLM depth, NBRx/TRx uplift), and what thresholds trigger refreshes?
• How should we integrate field reimbursement and medical engagement at key accounts while maintaining boundaries?
• What manager spans and district structures support coaching while containing travel burdens?
• Which systems (CRM, routing, dashboarding) will be in-scope; what integrations or mobile features are required?
• What change-management levers (incentives, contests, training cadence) will accelerate adoption and maintain morale during realignment?

6) Interview Guide for Subject Matter Experts

Head of Sales / Commercial Lead

• What performance gaps matter most (coverage, frequency, call quality, account outcomes), and where has the current model under-delivered?
• How do you prioritize headcount vs. productivity gains; what is the appetite for contract sales or co-promotion?
• Which markets/accounts are strategic and require dedicated coverage across roles?

Sales Operations / Analytics

• What data sources underpin current targeting; where are gaps in potential or affiliation accuracy?
• How do you calculate capacity and set call plans; where do adherence and CFT% break down?
• Which KPIs and dashboards are trusted by leadership; where does lineage need hardening?

Market Access / Field Reimbursement

• Which geos/plans impose the heaviest access frictions; how should call plans reflect PA/step edits and HUB performance?
• Which accounts require coordinated payer/provider engagement; how should roles be sequenced?

Medical Affairs (MSL Leadership)

• Where are scientific exchange needs high; which accounts benefit from MSL coordination with sales (within boundaries)?
• What KOL or protocol-influencer maps should inform account targeting?

Brand Marketing / Omnichannel

• Which messages and assets drive lift by segment; how can CLM and rep-triggered NPP augment live calls?
• What contact policies and suppression rules must govern cross-channel orchestration?

Regional/District Managers

• Where do travel time and territory size limit coaching; what good looks like for route planning?
• Which reps thrive under high-frequency plans; which require coaching or territory redesign?

CRM / IT / Data Governance

• What CRM fields are mandatory for call planning; where is data completeness lowest?
• How will routing integrate with CRM calendars; what mobile features are available?
• What access controls and audit trails govern targeting and sampling?

HR / Talent / Training

• What onboarding timelines and competencies affect coverage; how will we support realignment transitions?
• What incentive components align behavior with CFT% and quality outcomes?

Finance

• What budget constraints and ROI hurdles apply; how should we frame the headcount vs. productivity trade-offs?
• What reporting cadence and exhibits are required for board/investor communications?

7) Timeline

We executed a 12–14 week plan with decision gates tailored to Field Force Sizing And Territory Design within Sales.

• Weeks 1–2: Mobilize, Data Intake, and Diagnostic
  • Collected HCP/account masters, affiliations, claims/diagnostics, CRM history, access overlays, and geo data; baselined reach, CFT%, adherence, calls-per-day, and travel time.
  • Decision Gate A: Approved targeting objectives, KPIs, and modeling assumptions; aligned governance and change-management plan.
• Weeks 3–4: Potential Modeling and Target Segmentation
  • Built HCP/account potential model and micro-segmentation; validated with managers and MSLs; defined frequency bands and priority tiers.
  • Decision Gate B: Ratified segmentation and call frequency policy; locked inputs for sizing and territory design.
• Weeks 5–6: Field Force Sizing and Capacity Scenarios
  • Developed capacity model and headcount scenarios; assessed span-of-control and district structure; selected preferred option.
  • Decision Gate C: Approved headcount and management design; set hiring/onboarding plan and vacancy buffer.
• Weeks 7–8: Territory Design and Alignment
  • Executed geospatial clustering and affiliation-aware balancing; iterated with managers to address edge cases; finalized district/region maps.
  • Decision Gate D: Confirmed territory boundaries and transition plan; prepared HR/IT logistics.
• Weeks 9–10: Call Plan, Routing, and Omnichannel Integration
  • Configured CRM call plans and cadence rules; implemented routing engine and weekly planning templates; set rep-triggered NPP triggers and suppression windows.
  • Decision Gate E: Validated call plan and routing outputs; signed off on compliance hooks and sampling rules.
• Weeks 11–12: Dashboards, Training, and Go-Live
  • Deployed dashboards; ran manager and rep training (targeting, routing, account planning, CLM); launched realignment with cutover weekend.
  • Decision Gate F: Go-live readiness; agreed stabilization metrics and 30/60/90-day check-ins.
• Weeks 13–14 (Stabilization & Optimization)
  • Monitored KPIs; corrected data issues and routing exceptions; tuned frequency bands; captured field feedback for the next quarterly refresh.

Critical path items included HCP affiliation cleansing, access overlay availability, routing engine configuration, CRM call plan setup, manager bandwidth for iteration, compliance review of sampling/targeting, and change-management readiness for territory transitions.

8) Deliverables

• HCP/Account Potential Model and Target List
  • Eligible patient flow estimates, adoption propensity, access-adjusted tiers (A/B/C), and micro-segment profiles with recommended frequency bands.
• Field Force Sizing and Capacity Model
  • Headcount scenarios, calls-per-day assumptions by archetype, span-of-control design, and onboarding/vacancy buffer planning.
• Territory Alignment Maps and Files
  • Drive-time balanced territories and district/region hierarchies; GIS shapefiles and CRM import files; transition playbook.
• CRM Call Plan and Cadence Rules
  • Frequency targets (CFT%), priority lists, suppression windows, rep-triggered NPP triggers, and sampling/compliance hooks; upload-ready templates for CRM.
• Routing Playbook and Weekly Planner
  • Routing engine configuration, daily sequences, anchor appointment strategies, contingency plans, and mobile tooling guidance.
• Account-Based Coverage Toolkit (IDN)
  • Account maps, engagement sequencing, cross-functional SLAs, and account KPI dashboards (protocol adoption, diagnostic flow).
• Dashboard Suite and KPI Dictionary
  • Executive and field views for reach, CFT%, adherence, calls-per-day, travel time per call, CLM depth, NBRx/TRx by segment; lineage documentation.
• Change Management and Training Materials
  • Manager and rep training decks, quick-reference guides, ride-along checklists, incentive alignment brief, and FAQ.
• Compliance and Data Governance Pack
  • Targeting and sampling SOPs, access restriction flags, role-based access controls, and audit-ready documentation.

9) Industry Insights

Field excellence for biotech specialty therapeutics has evolved quickly; several trends inform Field Force Sizing And Territory Design within Sales.

• From deciles to dynamic potential:
  • Static deciles miss shifts in diagnostic intensity, payer policy, and system pathway changes. Dynamic potential models incorporating eligible patient flow and access adjusters outperform historic volume heuristics.
• Geospatial efficiency drives incremental calls:
  • Drive-time clustering and route sequencing routinely free 1–2 incremental calls/day in dense territories. Weekly planning discipline and time-windowing amplify gains and reduce burnout.
• Account-based models matter:
  • IDN and health system protocols shape adoption beyond individual prescribers. Coordinated account plans—aligned with field reimbursement and medical (within boundaries)—lift diagnostic flow and standard-of-care updates.
• Access-aware targeting boosts conversion:
  • Frequency should flex with PA/step edit intensity, HUB metrics, and formulary wins. Shifting calls from high-friction plans to access-enabled segments yields faster NBRx lift per call.
• Digital + rep orchestration:
  • Rep-triggered NPP and CLM follow-ups within 24–72 hours of high-quality in-person visits increase message retention and conversion; suppression windows prevent fatigue. Content modularity and CLM depth metrics improve call quality.
• Manager leverage through design:
  • District spans tuned to territory density and travel realities enable consistent coaching. Realignments should consider manager workloads, not only rep balancing.
• Data stewardship and privacy are differentiators:
  • Accurate affiliation mapping and clean HCP masters are prerequisites for good design; role-based access, de-identified analytics, and clear SOPs sustain compliance and trust.
• What “good” looks like:
  • Potential-driven targeting; capacity-based headcount; drive-time-balanced territories; access-aware call plans with high CFT%; routing that raises calls-per-day; account-based coverage; dashboards with lineage; quarterly refresh cadence; and an incentive plan aligned to quality and priority coverage.
• Near-term watch points:
  • Access volatility (PA/step edits), workforce constraints, and evolving privacy norms; maintain refresh cadence and governance to adapt call plans and territories without disruption.

Implications for the clients we served included enabling Emerging Therapeutic Biotech to stand up right-sized field coverage ahead of first launches; supporting Clinical-Stage Biotech with data-driven territories and call plans that convert access into NBRx lift; equipping Commercial Biotech with account-based, access-aware field operations and routing efficiency; guiding Platform Biotech to standardize targeting, alignment, and dashboards across partnered programs; and providing Biotech Investors & Incubators with a field productivity and ROI lens in diligence and value-creation planning.